U of Michigan institute, formerly the Center for Biologic Nanotechnology, for developing and commercializing biological and medical applications of nanotechnology.
James R. Baker Jr., M.D., the Ruth Dow Doan Professor of Biologic Nanotechnology and Chief of the Division of Allergy, serves as the Institute's first director.
NanoBio Corporation is a spinoff from this research effort.
